With the development of the cytokine theory of depression, it has been well documented that pro-inflammatory cytokines, including IL-1β, IFN, and TNF can reduce the bioavailability of neurotransmitters such as serotonin (5-HT) [139]. This evidence concerns the gene IL1B and depressive symptom measurement.